Perspectives on Regulatory T Cell Therapies

Publisher： Karger

E-ISSN： 1660-3818|36|5|302-308

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.36, Iss.5, 2009-09, pp. : 302-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

European regulatory perspectives for innovative therapies

By Ormarsdottir S.   Reginster J.-Y.   Abadie E.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 725-731

Springer Publishing Company

Access to resources Recommend Favorite

Regulatory considerations for the development of autologous induced pluripotent stem cell therapies

By Carpenter Melissa K   Couture Larry A  

Regenerative Medicine, Vol. 5, Iss. 4, 2010-07 ,pp. : 569-579

Future Medicine

Access to resources Recommend Favorite

Prevalence of Regulatory T‐Cell Subtypes in Preeclampsia

By  

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 74, Iss. 2, 2015-08 ,pp. : 110-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status and Perspectives of Stem Cell Based Therapies for Liver Diseases

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 3, 2011-09 ,pp. : 299-305

Bentham Science Publishers

Access to resources Recommend Favorite

In‐vitro effect of pembrolizumab on different T regulatory cell subsets

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 189-197

John Wiley & Sons Inc

Access to resources Recommend Favorite